title: Lack of interaction of hyperpnoea with methacholine and histamine in asthma.
abstract: 1. The thermal precipitants of asthma (exercise and hyperventilation) appear to have a unique pathogenesis that does not alter bronchial responsiveness. In the present work, we tested whether hyperpnoea interacts with other constrictor stimuli.2. To provide data on this issue, we exposed 17 subjects with asthma to isocapnic hyperventilation of frigid air (HV), methacholine (METH) and histamine (HIS) alone and in combination.3. With HV (mean ventilation=55.6+/-7.7 litres/min), METH (2.20+/-0.7 mmol/l) and HIS (10.35+/-5.04 mmol/l) alone, the decrements in forced expiratory volume in 1 s (FEV1) from baseline were 27.4+/-3.4, 27.4+/-3.8 and 32.4+/-3% respectively (n=9). Giving the agonists simultaneously did not produce additive effects (Delta FEV1 HV+METH=32.8+/-3.6%; HV+HIS=28.7+/-5.1%). None of the individual or combined responses was significantly different from each other. Changing the sequence of the experiments and giving METH at the height of the HV-induced bronchial narrowing, instead of during hyperpnoea, did not alter the findings (n=8). The maximum fall in FEV1 after both bronchoconstrictors in this experiment (Delta FEV1=32.3+/-4.3%) was not significantly different from either alone (HV=22.8+/-1.0%; METH=27.3+/-1.9%). When METH and HIS were administered together, however (n=5), a positive interaction ensued (METH=1.53+/-0.56 mmol/l, Delta FEV1=15.6+/-4.6%; HIS=4.77+/-2.07 mmol/l, Delta FEV1=18. 8+/-3.1%; METH+HIS Delta FEV1=33.4+/-5.2%; P<0.001 compared with the individual effects).4. These results indicate that HV does not interact with stimuli that directly or indirectly modulate airway calibre. It is unclear if this effect represents protection conferred from increased bronchial blood flow or derives from differences in effector mechanisms between the thermal and pharmacological agonists.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106-5067, USA.
authors.forename: S
authors.initials: S
authors.lastname: Sompradeekul
authors.forename: R
authors.initials: R
authors.lastname: Hejal
authors.forename: M
authors.initials: M
authors.lastname: McLane
authors.forename: K A
authors.initials: KA
authors.lastname: Lenner
authors.forename: J A
authors.initials: JA
authors.lastname: Nelson
authors.forename: E R
authors.initials: ER
authors.lastname: McFadden
mesh_terms: D000328:Adult; D001249:Asthma / Q000209:etiology / Q000503:physiopathology*; D001985:Bronchial Provocation Tests; D016085:Bronchoconstrictor Agents; D003080:Cold Temperature; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D015444:Exercise; D005260:Female; D005541:Forced Expiratory Volume / Q000187:drug effects; D006632:Histamine; D006801:Humans; D006985:Hyperventilation / Q000503:physiopathology*; D008297:Male; D016210:Methacholine Chloride
chemical_list: D016085:Bronchoconstrictor Agents; D016210:Methacholine Chloride; D006632:Histamine